Patent details

EP1636270 Title: ANTIBODIES SPECIFIC FOR SCLEROSTIN AND METHODS FOR INCREASING BONE MINERALIZATION

  • Data
  • Documents

Basic Information

Publication number:
EP1636270
PCT Application Number:
PCT/US/2004/018912
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP047765532
PCT Publication Number:
WO/2005/014650
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
ANTIBODIES SPECIFIC FOR SCLEROSTIN AND METHODS FOR INCREASING BONE MINERALIZATION
French Title of Invention:
ANTICORPS SPECIFIQUES DE LA SCLEROSTINE ET METHODES PERMETTANT D'ACCROITRE LA MINERALISATION OSSEUSE
German Title of Invention:
SPEZIFISCHE ANTIKÖRPER FÜR SCLEROSTIN UND VERFAHREN ZUR ERHÖHUNG DER KNOCHENMINERALISIERUNG
SPC Number:

Dates

Filing date:
15/06/2004
Grant date:
20/07/2016
EP Publication Date:
20/07/2016
PCT Publication Date:
17/02/2005
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
22/03/2006
EP B1 Publication Date:
20/07/2016
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
15/06/2017
Expiration date:
15/06/2024
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
15/06/2004
 
 

Name:
UCB Pharma S.A.
Address:
Allée de la Recherche 60, 1070 Brussels, Belgium (BE)

Inventor

1

Name:
LATHAM John
Address:
United States (US)

2

Name:
SHI Jiye
Address:
United States (US)

3

Name:
WINKLER David, G.
Address:
United States (US)

Priority

Priority Number:
478977 P
Priority Date:
16/06/2003
Priority Country:
United States (US)

Classification

Main IPC Class:
C07K 16/22;
Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer: